Showing results (401-410 of 416) with videos related to
Sort By:
Pageof 42
American Journal of Hematology|April 27, 2013
A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphomaThomas E Witzig, Gregory A Wiseman, Matthew J Maurer, et al.Proceedings of the National Academy of Sciences of the United States of America|August 6, 2014
Protective hinge in insulin opens to enable its receptor engagementJohn G Menting, Yanwu Yang, Shu Jin Chan, et al.Mbio|July 27, 2021
Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus MacaquesKim J Hasenkrug, Friederike Feldmann, Lara Myers, et al.Nature Chemical Biology|April 23, 2013
Structure-guided design of a selective BCL-X(L) inhibitorGuillaume Lessene, Peter E Czabotar, Brad E Sleebs, et al.Science (New York, N.Y.)|January 6, 2018
Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivaxJakub Gruszczyk, Usheer Kanjee, Li-Jin Chan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2019
First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed GlioblastomaBryan G Allen, Kellie L Bodeker, Mark C Smith, et al.Nature|January 15, 2025
Pathogenesis of bovine H5N1 clade 2.3.4.4b infection in macaquesKyle Rosenke, Amanda Griffin, Franziska Kaiser, et al.Radiation Research|April 25, 2017
Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic Cancer: The University of Iowa Experience of Two Phase 1 Clinical TrialsAmir Zahra, Melissa A Fath, Emyleigh Opat, et al.Redox Biology|December 1, 2020
Magnetic resonance imaging (MRI) of pharmacological ascorbate-induced iron redox state as a biomarker in subjects undergoing radio-chemotherapyCameron M Cushing, Michael S Petronek, Kellie L Bodeker, et al.Emerging Microbes & Infections|January 2, 2024
In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primatesAmi Patel, Kyle Rosenke, Elizabeth M Parzych, et al.Pageof 42